In a discovery that has left researchers stunned, a team from the University of Gothenburg has revealed that newborn babies exhibit high levels of p‑tau217—a protein commonly recognised as a critical early warning sign of Alzheimer's disease in adults.
This unexpected find could revolutionise our understanding of neurodevelopment and offer a new roadmap for early treatments.
